In Iran, as elsewhere, GLP-1 agonists such as semaglutide and tirzepatide offer a chance to address obesity, improve organ functioning and treat various chronic health conditions. The drugs are also ...
In Iran, as elsewhere, GLP-1 agonists such as semaglutide and tirzepatide offer a chance to address obesity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results